• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内镜治疗与手术切除治疗老年结直肠神经内分泌肿瘤的效果比较。

Endoscopic therapy versus surgical resection for elderly patients with colorectal neuroendocrine tumors.

机构信息

Department of Endoscopy Center, The First People's Hospital of Kunshan, Suzhou, China.

Department of Gastroenterology, Changshu Hospital Affiliated to Soochow University, Suzhou, China.

出版信息

Surg Endosc. 2024 Nov;38(11):6356-6367. doi: 10.1007/s00464-024-11220-z. Epub 2024 Aug 30.

DOI:10.1007/s00464-024-11220-z
PMID:39214875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11525421/
Abstract

BACKGROUND

Endoscopic therapy (ET) and surgical resection (SR) are common surgical methods for the treatment of colorectal neuroendocrine tumors (CRNETs). However, for elderly patients, it remains unclear which surgical method yields better long-term outcomes.

METHODS

Elderly patients ≥ 65 years with CRNETs diagnosed from 2000 to 2020 were identified from the Surveillance, Epidemiology, and End Results database. Propensity score matching (PSM) was used to minimize selection bias. The Kaplan-Meier method and Cox proportional hazards models were utilized to evaluate the effects of diverse demographic and clinical factors on overall survival (OS) and cancer-specific survival (CSS).

RESULTS

A total of 2214 patients were included in the study, with 1417 patients in the ET group and 797 patients in the SR group. After PSM, the ET group outperformed the SR group in terms of OS (hazard ratio [HR] 0.56, 95% confidence interval [CI] 0.44-0.70) and CSS (HR 0.21, 95% CI 0.11-0.40). Similarly, the ET group maintained its advantage in mean 1-, 3-, and 5-year OS and CSS rates compared to the SR group (P < 0.001). Multivariate Cox regression analysis identified age, sex, grade, marital status, and treatment modality as independent risk factors affecting OS, while age, sex, marital status, and treatment modality were identified as independent risk factors affecting CSS.

CONCLUSIONS

ET offered superior long-term outcomes for elderly patients ≥ 65 years with CRNETs.

摘要

背景

内镜治疗(ET)和手术切除(SR)是治疗结直肠神经内分泌肿瘤(CRNET)的常见手术方法。然而,对于老年患者,哪种手术方法能获得更好的长期结果仍不清楚。

方法

从监测、流行病学和最终结果数据库中确定了 2000 年至 2020 年期间诊断为 CRNET 的年龄≥65 岁的老年患者。采用倾向评分匹配(PSM)以最小化选择偏差。Kaplan-Meier 方法和 Cox 比例风险模型用于评估不同的人口统计学和临床因素对总生存(OS)和癌症特异性生存(CSS)的影响。

结果

共有 2214 例患者纳入研究,其中 ET 组 1417 例,SR 组 797 例。PSM 后,ET 组的 OS(风险比 [HR] 0.56,95%置信区间 [CI] 0.44-0.70)和 CSS(HR 0.21,95% CI 0.11-0.40)均优于 SR 组。同样,与 SR 组相比,ET 组在平均 1 年、3 年和 5 年 OS 和 CSS 率方面也保持优势(P<0.001)。多变量 Cox 回归分析确定年龄、性别、分级、婚姻状况和治疗方式是影响 OS 的独立危险因素,而年龄、性别、婚姻状况和治疗方式是影响 CSS 的独立危险因素。

结论

ET 为年龄≥65 岁的 CRNET 老年患者提供了更好的长期结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0710/11525421/89e9626bc5f1/464_2024_11220_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0710/11525421/0d9a0650edd6/464_2024_11220_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0710/11525421/588b2e7b218f/464_2024_11220_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0710/11525421/7c40e028c71c/464_2024_11220_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0710/11525421/1e7b1a3052f2/464_2024_11220_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0710/11525421/89e9626bc5f1/464_2024_11220_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0710/11525421/0d9a0650edd6/464_2024_11220_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0710/11525421/588b2e7b218f/464_2024_11220_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0710/11525421/7c40e028c71c/464_2024_11220_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0710/11525421/1e7b1a3052f2/464_2024_11220_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0710/11525421/89e9626bc5f1/464_2024_11220_Fig5_HTML.jpg

相似文献

1
Endoscopic therapy versus surgical resection for elderly patients with colorectal neuroendocrine tumors.内镜治疗与手术切除治疗老年结直肠神经内分泌肿瘤的效果比较。
Surg Endosc. 2024 Nov;38(11):6356-6367. doi: 10.1007/s00464-024-11220-z. Epub 2024 Aug 30.
2
Long-term survival outcomes of endoscopic therapy vs. surgical resection in patients with cardia gastrointestinal stromal tumor.内镜治疗与手术切除治疗贲门胃肠间质瘤患者的长期生存结局比较。
PLoS One. 2024 Jul 5;19(7):e0306598. doi: 10.1371/journal.pone.0306598. eCollection 2024.
3
Long-term outcomes of endoscopic therapy versus surgical resection for 2-5 cm gastric gastrointestinal stromal tumors: A population-based comparative study.内镜治疗与手术切除 2-5cm 胃胃肠间质瘤的长期疗效比较:一项基于人群的对照研究。
Eur J Surg Oncol. 2024 Jun;50(6):108262. doi: 10.1016/j.ejso.2024.108262. Epub 2024 Mar 15.
4
The influence of lymphadenectomy on the prognosis of small intestinal stromal tumors: a study based on the SEER database.基于 SEER 数据库的研究:淋巴结清扫术对小肠间质瘤预后的影响。
Surg Endosc. 2024 Jul;38(7):3838-3848. doi: 10.1007/s00464-024-10906-8. Epub 2024 May 31.
5
Endoscopic and Surgical Treatment of Gastrointestinal Neuroendocrine Neoplasms: A Population-based Comparative Study.胃肠神经内分泌肿瘤的内镜和外科治疗:一项基于人群的对比研究。
Surg Laparosc Endosc Percutan Tech. 2024 Aug 1;34(4):366-375. doi: 10.1097/SLE.0000000000001291.
6
Endoscopic and surgical treatment of T1N0M0 colorectal neuroendocrine tumors: a population-based comparative study.T1N0M0期结直肠神经内分泌肿瘤的内镜和手术治疗:一项基于人群的比较研究
Surg Endosc. 2022 Apr;36(4):2488-2498. doi: 10.1007/s00464-021-08535-6. Epub 2021 May 13.
7
Comparing surgical and endoscopic resection approaches for colorectal neuroendocrine tumors within the diameter range of 10-20mm: an inverse probability weighting analysis based on the SEER database.比较直径范围在 10-20mm 的结直肠神经内分泌肿瘤的手术和内镜切除方法:基于 SEER 数据库的逆概率加权分析。
Front Endocrinol (Lausanne). 2024 Mar 27;15:1378968. doi: 10.3389/fendo.2024.1378968. eCollection 2024.
8
Marital status, an independent predictor for survival of gastric neuroendocrine neoplasm patients: a SEER database analysis.婚姻状况是胃神经内分泌肿瘤患者生存的独立预测因素:一项 SEER 数据库分析。
BMC Endocr Disord. 2020 Jul 23;20(1):111. doi: 10.1186/s12902-020-00565-w.
9
Comparable long-term survival outcomes of endoscopic therapy versus surgical therapy for T1-2N0M0 duodenal neuroendocrine tumors.内镜治疗与手术治疗 T1-2N0M0 期十二指肠神经内分泌肿瘤的长期生存结局相当。
Surg Endosc. 2023 Jul;37(7):5444-5452. doi: 10.1007/s00464-023-10019-8. Epub 2023 Apr 10.
10
Effects of endoscopic therapy and surgical resection on long-term survival outcomes in patients with duodenal gastrointestinal stromal tumors: a surveillance, epidemiology, and end result program analysis.内镜治疗与手术切除对十二指肠胃肠道间质瘤患者长期生存结局的影响:一项监测、流行病学及最终结果项目分析
Surg Endosc. 2022 Nov;36(11):8030-8038. doi: 10.1007/s00464-022-09231-9. Epub 2022 Apr 18.

本文引用的文献

1
When is neoadjuvant chemotherapy indicated in rectal neuroendocrine tumors? An analysis of the National Cancer Database.新辅助化疗在直肠神经内分泌肿瘤中的适应证是什么?基于国家癌症数据库的分析。
Tech Coloproctol. 2024 May 21;28(1):56. doi: 10.1007/s10151-024-02927-1.
2
Endoscopic treatments for rectal neuroendocrine tumors: a systematic review and network meta-analysis.内镜治疗直肠神经内分泌肿瘤:系统评价和网络荟萃分析。
J Gastrointest Surg. 2024 Mar;28(3):301-308. doi: 10.1016/j.gassur.2023.12.016. Epub 2024 Jan 23.
3
Postprocedure serum amylase or lipase levels predict postendoscopic retrograde cholangiopancreatography pancreatitis: Meta-analysis of diagnostic test accuracy studies and utility assessment.
术后血清淀粉酶或脂肪酶水平可预测内镜逆行胰胆管造影术后胰腺炎:诊断试验准确性研究及效用评估的荟萃分析
Dig Endosc. 2024 Jun;36(6):670-687. doi: 10.1111/den.14718. Epub 2023 Dec 11.
4
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours.欧洲神经内分泌肿瘤学会(ENETS)2023 年结直肠神经内分泌肿瘤指南。
J Neuroendocrinol. 2023 Jun;35(6):e13309. doi: 10.1111/jne.13309. Epub 2023 Jun 22.
5
Efficacy of Endoscopic Resection for Rectal Neuroendocrine Tumors Smaller than 15 mm.内镜切除直径小于 15mm 的直肠神经内分泌肿瘤的疗效。
Dig Dis Sci. 2023 Jul;68(7):3148-3157. doi: 10.1007/s10620-023-07914-4. Epub 2023 Apr 6.
6
Recent progress of experimental model in pancreatic neuroendocrine tumors: drawbacks and challenges.胰腺神经内分泌肿瘤实验模型的最新进展:缺点与挑战
Endocrine. 2023 May;80(2):266-282. doi: 10.1007/s12020-023-03299-6. Epub 2023 Jan 17.
7
Long-term clinical outcomes of endoscopic submucosal dissection in rectal neuroendocrine tumors based on resection margin status: a real-world study.基于切缘状态的直肠神经内分泌肿瘤内镜黏膜下剥离术的长期临床结局:一项真实世界研究
Surg Endosc. 2023 Apr;37(4):2644-2652. doi: 10.1007/s00464-022-09710-z. Epub 2022 Nov 15.
8
Marital status and survival in cancer patients: A systematic review and meta-analysis.婚姻状况与癌症患者生存:系统评价和荟萃分析。
Cancer Med. 2023 Jan;12(2):1685-1708. doi: 10.1002/cam4.5003. Epub 2022 Jul 4.
9
Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance.直肠神经内分泌肿瘤:管理、治疗和监测的最新进展。
World J Gastroenterol. 2022 Mar 21;28(11):1123-1138. doi: 10.3748/wjg.v28.i11.1123.
10
Long-term outcomes of transanal endoscopic microsurgery for the treatment of rectal neuroendocrine tumors.经肛门内镜微创手术治疗直肠神经内分泌肿瘤的长期疗效。
BMC Surg. 2022 Feb 5;22(1):43. doi: 10.1186/s12893-022-01494-2.